Gene Symbol: RPL3 (Ribosomal Protein L3)
Chromosomal Location: 22q12.1
NCBI Gene ID: 6122
UniProt ID: P35978
RPL3 encodes Ribosomal Protein L3, a fundamental component of the large (60S) ribosomal subunit. As one of approximately 47 ribosomal proteins in the eukaryotic 60S subunit, RPL3 plays essential roles in ribosome assembly, protein synthesis, and specifically the peptidyl transferase catalytic activity that underlies peptide bond formation. While traditionally viewed as a "housekeeping" protein essential for cell survival, emerging research reveals important neuron-specific functions and clear dysregulation in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). RPL3 has emerged as a critical player in synaptic protein synthesis, neuronal stress responses, and the regulation of disease-specific protein translation.
RPL3 is particularly notable for its position at the peptidyl transferase center (PTC) of the ribosome, where it directly contributes to the catalytic mechanism of peptide bond formation. This central role in protein synthesis makes RPL3 a key determinant of translational capacity in neurons, which have exceptionally high protein synthesis demands due to their complex morphology, synaptic plasticity requirements, and long axonal projections. The dysfunction of RPL3 in neurodegeneration thus represents a fundamental impairment of cellular proteostasis that cascades into multiple pathological pathways.
The human RPL3 gene spans approximately 6.5 kb on chromosome 22q12.1 and consists of:
RPL3 is a 397-amino acid protein with a molecular weight of approximately 43.2 kDa. Key structural features include:
The protein contains:
Within the 60S subunit, RPL3 is located:
RPL3 is ubiquitously expressed across all tissues, with highest levels in:
| Region | Expression Level | Notes |
|---|---|---|
| Cerebral Cortex | High | Pyramidal neurons in layers II-V |
| Hippocampus | High | CA1-CA3 pyramidal cells, dentate gyrus granule cells |
| Cerebellum | High | Purkinje cells and granule cells |
| Basal Ganglia | Moderate-High | Striatal medium spiny neurons |
| Substantia Nigra | Moderate-High | Dopaminergic neurons |
| Spinal Cord | Moderate | Motor neurons |
| Thalamus | Moderate | Relay neurons |
Ribosomal dysfunction is a well-documented and early feature of AD pathogenesis, with RPL3 playing a central role:
Translational deficit: Significant reduction in global translation rates in AD brains correlates strongly with cognitive decline. RPL3 protein levels are consistently altered in vulnerable brain regions including the hippocampus and frontal cortex[@cheng2019].
Ribosome assembly defects: Impaired 60S subunit biogenesis leads to decreased translational capacity. RPL3 phosphorylation states are altered in AD[@liu2020].
Synaptic translation impairment: Synaptic dysfunction in AD involves specific deficits in the synaptic translation machinery. RPL3 in synaptosomes shows decreased activity and altered post-translational modifications[@yang2019].
Tau pathology relationship: Ribosomal dysfunction precedes tau aggregation in multiple model systems. RPL3 interacts with tau pathology markers[@ding2020].
Amyloid-beta (Aβ) effects: Aβ oligomers directly impair ribosomal function through:
In PD, RPL3 dysregulation contributes to multiple aspects of pathogenesis:
Dopaminergic neuron vulnerability: Reduced translation capacity makes dopaminergic neurons in the substantia nigra particularly susceptible to cellular stress[@kim2019].
α-Synuclein translation: Altered ribosomal function affects α-synuclein synthesis rates, potentially creating a feed-forward pathological loop.
Mitochondrial stress response: RPL3 coordinates stress response translation, including mitochondrial protein synthesis during cellular stress[@liu2018].
Protein homeostasis failure: Impaired translation contributes to aggresome formation and proteostasis failure characteristic of PD.
Lewy body pathology: RPL3 alterations are observed in Lewy body diseases including PD and Dementia with Lewy Bodies (DLB)[@parkinson2021].
RPL3 in ALS pathogenesis:
Motor neuron-specific vulnerability: Motor neurons have extremely high translational demands, making them particularly sensitive to ribosomal alterations.
Stress granule formation: RPL3 is recruited to stress granules in ALS models, where it may regulate the translation of specific stress response mRNAs.
C9orf72 translation: Dysregulated translation of hexanucleotide repeat expansion transcripts involves ribosomal protein alterations.
RNA granule dynamics: RPL3 participates in RNA granule trafficking in neurons, with alterations in ALS.
RPL3 participates in several essential translation processes:
| Partner | Interaction | Functional Effect |
|---|---|---|
| 28S rRNA | Direct binding | Ribosome structural integrity |
| RPL5 | Protein interaction | 60S central core |
| RPL11 | Complex formation | 60S subunit stability |
| eEF-1A | Factor binding | Translation elongation |
| eEF-2 | Factor binding | Translocation |
| RPL23 | Ribosomal protein interaction | Assembly |
mRNA → 43S pre-initiation complex → 48S initiation complex
↓
60S subunit joining
↓
RPL3-PTC function
↓
Peptide bond formation
↓
Elongation → Termination
RPL3 serves as an integrator of cellular stress responses:
Integrated stress response (ISR): Phosphorylation of eIF2α reduces global translation while selectively translating specific stress response mRNAs. RPL3 helps direct this selective translation[@wang2021].
Unfolded protein response (UPR): Ribosomal quality control initiates UPR signaling in ER stress, with RPL3 participating in translational attenuation.
Oxidative stress: Translation arrest protects against oxidative damage. RPL3 oxidation alters its function under oxidative conditions.
Nutrient deprivation: RPL3 modifications adapt translation to nutrient availability through mTOR signaling crosstalk.
DNA damage: Ribosomal proteins including RPL3 coordinate translation with DNA damage response pathways.
Ribosomal dysfunction has emerged as a key mechanism in neurodegeneration, with RPL3 at the crossroads:
Post-mortem brain studies have consistently demonstrated RPL3 alterations in neurodegenerative diseases:
RPL3 plays critical roles in synaptic function:
RPL3 is essential for learning and memory:
| Drug | Known Target | Potential RPL3 Effect |
|---|---|---|
| Rapamycin | mTORC1 | Enhances translation |
| ISRIB | eIF2α | Modulates ISR |
| Ribavirin | eIF4E | Translation inhibition |
| Gadolinium | Ribosome | Potential stabilizer |
RPL3 is highly conserved across species:
| Organism | RPL3 Homolog | Research Utility |
|---|---|---|
| S. cerevisiae | RPL3 | Ribosome structure |
| D. melanogaster | RpL3 | Development |
| C. elegans | rpl-3 | Neurobiology |
| D. rerio | rpl3 | Development |
| M. musculus | Rpl3 | Mammalian model |